An, D.; Yu, X.; Jiang, L.; Wang, R.; He, P.; Chen, N.; Guo, X.; Li, X.; Feng, M.
Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment. Molecules 2021, 26, 1280.
https://doi.org/10.3390/molecules26051280
AMA Style
An D, Yu X, Jiang L, Wang R, He P, Chen N, Guo X, Li X, Feng M.
Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment. Molecules. 2021; 26(5):1280.
https://doi.org/10.3390/molecules26051280
Chicago/Turabian Style
An, Duopeng, Xiaochen Yu, Lijing Jiang, Rui Wang, Peng He, Nanye Chen, Xiaohan Guo, Xiang Li, and Meiqing Feng.
2021. "Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment" Molecules 26, no. 5: 1280.
https://doi.org/10.3390/molecules26051280
APA Style
An, D., Yu, X., Jiang, L., Wang, R., He, P., Chen, N., Guo, X., Li, X., & Feng, M.
(2021). Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment. Molecules, 26(5), 1280.
https://doi.org/10.3390/molecules26051280